LON:VAL

ValiRx Interim Earnings Results & Report

ValiRx logo
GBX 0.14 -0.02 (-10.00%)
As of 12:28 PM Eastern

ValiRx reported Interim earnings on September 29, 2025. The company reported EPS of -GBX 0.22.

Earnings Announcement Details

Quarter
Interim
Time
Before Market Opens

ValiRx EPS Results

Actual EPS
-GBX 0.22
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ValiRx Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

ValiRx Interim Earnings FAQ

ValiRx (LON:VAL) reported earnings of -GBX 0.22 per share for Interim. The report was announced on Monday, September 29, 2025.

ValiRx Earnings Headlines

Update on Ambrose Healthcare shareholding
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
See More ValiRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ValiRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ValiRx and other key companies, straight to your email.

About ValiRx

ValiRx (LON:VAL) accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

View ValiRx Profile